An overview of pharmacotherapy-induced ototoxicity

Pharmacotherapy in Anorexia Nervosa: An Overview

Anorexia Nervosa (AN) is a serious, debilitating and potentially lethal disease because of the marked dysfunctions it evokes. Therapy for AN is essentially multidisciplinary, with nutritional, medical and psychotherapeutic interventions. Many drugs, particularly psychoactive agents, have been tested during the past decades, trying to improve the clinical and psychopathological conditions on the...

An Overview of Pharmacotherapy of Obesity: an Update

Obesity is a chronic disease and a major health problem which require long term treatment in developed and affluent society of developing countries. Pharmacotherapies for obesity have to be given for a long duration with lifestyle modifications. Anti-obesity drugs acts through various targets in the body which reduce the food intake, decrease absorption and increase metabolism. Many drugs were ...

Establishing a pharmacotherapy induced ototoxicity programme within a service-learning approach

Pharmacotherapy-induced ototoxicity is growing, especially in developing countries such as South Africa. This highlights the importance of ototoxicity monitoring and management of hearing loss. This article focuses on the establishment of an ototoxicity clinic as a site for the implementation of a service-learning module in the Audiology programme. The clinic offers a unique opportunity of coll...

An Overview of Candiduria

Candida microorganisms frequently exist as saprophytes on the external genitalia or urethra, however, yeast in measurable quantities are found in <1% of clean voided urine specimens. The overall frequency of Candida infections in hospitals has increased by 200% to 300% in the last decade, such that in a general hospital 5% of urine cultures may yield Candida species, and in tertiary-care center...

Continuing Education Drug - Induced Ototoxicity